Sonic Fund Ii, L.P. Fennec Pharmaceuticals Inc. Transaction History

Sonic Fund Ii, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.51 - $9.62 $168,433 - $248,898	-25,873 Reduced 1.06%	2,407,357 $22.7 Million
Q2 2021 Aug 16, 2021	BUY	$5.96 - $7.85 $14.5 Million - $19.1 Million	2,433,230 New	2,433,230 $17.7 Million
Q2 2021 Aug 16, 2021	SELL	$5.96 - $7.85 $14.5 Million - $19.1 Million	-2,433,230 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.99 - $8.55 $4.78 Million - $6.83 Million	798,541 Added 48.85%	2,433,230 $18.1 Million
Q2 2020 Aug 14, 2020	BUY	$5.43 - $9.39 $4.34 Million - $7.51 Million	800,000 Added 95.84%	1,634,689 $13.7 Million
Q4 2019 Feb 14, 2020	BUY	$4.25 - $6.49 $3.55 Million - $5.42 Million	834,689 New	834,689 $5.42 Million

14.8M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $169M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Sonic Fund Ii, L.P., based on Form 13F filings with the SEC.

Stay updated on Sonic Fund Ii, L.P. with notifications on news.